Atypical presentation of Takayasu’s arteritis in an adolescent by Binnetoğlu, Kıymet et al.
Marmara Medical Journal 2015; 28: 157-160
DOI: 10.5472/MMJcr.2803.01
   CASE REPORT / OLGU SUNUMU
157
ABSTRACT
Takayasu`s arteritis is rarely seen in childhood. In addition, 
symptoms are nonspecific and diagnostic laboratory marker is 
unavailable. We hereby described an adolescent with an atypical 
presentation of Takayasu`s arteritis. A 15-year-old girl was admitted 
to our clinic with the symptoms of weight loss, fever, back pain, and 
malaise since 2 months. Physical examination ended with normal 
vital signs, centiles and no other pathological findings. Laboratory 
findings showed increased acute phase reactants. Irregularities 
in the aortic wall and luminal narrowing of aorta were detected 
in magnetic resonance angiography. In conclusion, children with 
Takayasu`s arteritis  present with nonspecific symptoms. No 
laboratory test is diagnostic, whereas abnormalities in large vessels 
in radiology are specific for the disease. Mainstay of treatment is 
systemic steroids and immunosuppressants and outcome is worse 
in children than in adults.
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ÖZET
Takayasu arteriti çocuklarda nadir görülen bir hastalıktır. Klinik 
bulgular özgün değildir ve tanısal bir laboratuvar test mevcut 
değildir. Burada, atipik bir klinikle başvuran bir ergende Takayasu 
arteriti sunulmaktadır. Onbeş yaşında kız çocuk kliniğimize 2 
aydır süren kilo kaybı, ateş, halsizlik ve sırt ağrısı ile başvurdu. 
Fizik muayenede büyüme gelişmesi normal olan hastada 
patolojik bulguya rastlanmadı.  Laboratuvar testlerinde akut faz 
reaktanları yüksek bulundu. Manyetik resonans ile anjiografik 
görüntülemelerde aorta duvarında düzensizlik ve daralmalar 
saptandı. Sonuç olarak, çocuklarda Takayasu arteritinde non-
spesifik bulgular görülmektedir. Laboratuvar testleri tanısal 
olmamakla beraber radyolojik bulgular oldukça özgündür. 
Tedavide sistemik steroidler ve immusupresanlar kullanılmakta 
ancak çocuklarda seyir erişkinlerden daha ağır olmaktadır. 
Anahtar kelimeler: Ergen, HLAB51, Takayasu arteriti, Vaskülit 
Introduction
Fever of unknown origin in childhood has broad categories 
of illnesses as underlying causes. More common etiologies 
should be searched initially such as systemic or localized 
infections followed by malignancies. Rheumatologic 
diseases are less common in etiology. Among those 
Takayasu’s arteritis is very rarely seen in childhood. In 
addition, symptoms are nonspecific and a diagnostic 
laboratory marker is unavailable [1-3]. Early diagnosis and 
treatment is vital especially in children for a better outcome. 
We hereby described an adolescent with an atypical 
presentation of Takayasu’s arteritis at an early phase of this 
disease.
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Case Report
A 15-year-old girl was admitted with the symptoms of 
weight loss, fever, back pain, fatigue and malaise for the last 
2 months. Past medical history revealed hospital admission 
with vomiting and diarrhea due to Entamoeba hystolitica. 
Her family history revealed Behçet’s disease in an uncle. 
Physical examination ended with normal vital signs and 
centiles. Laboratory findings showed increased acute phase 
reactants; WBC: 9.2 103/uL, absolute neutrophile count: 
5.500/uL, ESR: 98 mm/hour and CRP:54mg/lt (0-5mg/
lt). Differential diagnosis was not compatible with blastic 
transformation. Procalcitonine level was 0.06pg/mL (<10 
pg/mL) which was  not indicative of an infectious etiology. 
Blood and urine biochemistries were in normal range for 
the age. Following the initial work-up, she necessitated 
further evaluation for weight loss and night fever primarily 
for infectious agents such as brucellosis, typhoid fever and 
tuberculosis. Wright, Gruber Widal, stool cultures, ppd 
and quantiferon assays were all negative. Viral serologies 
for CMV, EBV and HIV were also found to be negative. 
Cardiac examination, blood cultures and echocardiography 
were not suggestive for infective endocarditis. Connective 
tissue and inflammatory bowel diseases were also 
considered for this patient. Daily abdominal pain with a 
short duration of 10 minutes was the only positive finding 
in her history. On the other hand, patient had negative ANA, 
anti dsDNA, c-ANCA, p-ANCA with borderline positive 
rheumatoid factor: 26.1IU/ml (<23IU/ml). She had negative 
HLA-B27 but positive HLA-B51 titers with a negative 
pathergy testing. Abdominal and thoracic computed 
tomographies were performed to rule-out localized abscess 
or solid tumor. Interestingly, thorax tomography showed 
annular type thickening of great vessels’ wall (Figure 
1A, 1B, 1C) with normal pulmonary arteries. To explore 
those changes more, magnetic resonance angiography was 
performed. Irregularities in the aortic wall both in thoracic 
and abdominal section, luminal narrowing of aorta both 
above and below diaphragmatic level were detected (Figure 
2A, 2B). These radiological findings in large arterial vessels 
were compatible with Takayasu’s arteritis. 
Putting all these subtle clinical and diagnostic 
radiological features together, patient most likely had early 
phase Takayasu’s arteritis. Absence of hypertension in all 
extremities, headache, claudicating extremities, and audible 
bruit in this patient was compatible with the early phase 
and atypical presentation of this disease. She was treated 
with 1mg/kg/day methylprednisolone. One week after the 
treatment, her symptoms regressed including malaise, 
fatigue, and fever and she started to gain weight. In addition, 
ESR and CRP levels returned to normal range at the 1st 
month follow-up visit. Steroid therapy was continued for 1 
month at a dose of 1mg/kg/day and following schedule was 
as planned as 20% taper of steroid dose every two weeks. 
Steroid dose could not be tapered at 2nd month due to reversal 
of nonspecific symptoms and 2mg/kg/day azathiopurine 
was added for steroid sparing effect. 
Figure 1. A) Thickening of thoracic aorta wall at axial thoracic 
imaging, B) Luminal irregularities of the thoracic aorta wall at 
coronal  thoracic imaging and C) Thoracoabdominal aortic wall 
tortuosity and thickening at sagittal thoracoabdominal imaging. 
Figure 2. A) Wall thickening and narrowing of the right subclavian 
artery at the level of vertebral artery origin at contrast enhanced 
cervical imaging, B and C) Narrowing and wall irregularities at 
the diaphragmatic level and infrarenal abdominal aorta at contrast 
enhanced thoracoabdominal magnetic resonance imaging
Discussion
Takayasu’s arteritis is the most common, granulomatous 
inflammation of large arteries. Disease has an acute early 
phase, with non-specific symptoms such as hypertension, 
headache, fever, muscle pain, arthralgia, night sweats and 
weight loss. Due to the non-specific symptoms and the 
absence of specific laboratory parameters, the disease is often 
unrecognized in this phase. To date, Takayasu’s arteritis is 
a rarely described disease in pediatric age group with only 
a few studies [1-3]. These patients were mostly admitted 
with less specific symptoms than in adults such as fever, 
arthralgias and hypertension [4]. For the initial admission in 
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children, the typical presenting symptoms and findings was 
reported to be headache (31%) and hypertension in physical 
examination (82%) [4,5]. The patient in this report did not 
complain about headache and had normal blood pressure 
in all extremities. These symptoms  were  atypical for 
Takayasu’s arteritis. Rarely  seen symptoms such as fever 
(29%), dyspnea (23%), weight loss (22%) and vomiting 
(20%) [4] were  prominent in our patient  at admission.  
Ozen et al revised the diagnostic criteria of Takayasu’s 
arteritis as follows in 2010; mandatory angiographic 
abnormalities of the aorta or its main branches and pulmonary 
arteries showing aneurysm/dilatation plus one of the five 
following criteria: 1.pulse deficit or claudication, 2.four 
limbs blood pressure discrepancy, 3.bruits, 4.hypertension, 
5.elevated acute phase reactants [6]. According to those 
revised criteria, our patient met 2 of them: increased 
acute phase reactants and the mandatory and diagnostic 
radiological findings.
Regarding Takayasu’s arteritis, human leukocyte 
antigen risk alleles for various populations are studied. 
Indian subjects were found to be associated with HLA-B5 
and its two serological subtypes, B51 and B52 [7]. Recently 
Sahin et al described that Takayasu’s arteritis was found to 
be associated with HLA-B*52, but not with HLA-B*51, 
in Turkey [8]. Our patient was positive for HLA B51 with 
a family history of Behçet’s disease. Currently, human 
leukocyte antigen risk alleles do not provide diagnostic or 
prognostic features for patients with Takayasu’s arteritis
Adequate therapy in Takayasu’s arteritis is important 
to prevent irreversible vessel damage  resulting with 
insufficiency of vital organs. Corticosteroids are 
still the mainstay of treatment [9]. In addition, other 
immunosuppressive agents such as methotrexate, 
azathiopurine and cyclophosphamide are other therapeutic 
options [10]. In about one-fourth of the treated patients, 
remission was not achieved but relapses observed. 
Addition of anti-TNF therapy may be a possible beneficial 
agent for these patients [11,12]. Despite providing short-
term benefit, endovascular revascularization procedures 
(bypass grafts, patch angioplasty, endarterectomy, 
percutaneous transluminal angioplasty, stent placement) 
are associated with a high failure rate in patients with 
Takayasu’s arteritis [13,14]. Patient reported here initially 
received  steroid therapy which was followed by a systemic 
immunosuppressant agent (azathiopurine). She did not need 
anti-TNF or vascular intervention yet, but may be essential 
in the long term outcome. 
Anti-inflammatory therapy can lead to dramatic 
improvement in symptoms of Takayasu’s arteritis. Although 
improvement of symptoms usually follows glucocorticoid 
therapy, relapses usually occur with dosage reduction 
[15]. Five-year survival rate in adults is as high as 94% 
[15], whereas mortality rate in children is around 35% [2]. 
Mortality is related to hypertension, pulmonary vascular 
involvement, renal and cardiac failure [16]. In our patient, 
early diagnosis and initiation of steroid treatment rendered 
in remission of clinical symptoms and acute phase reactants, 
as expected. Follow-up of this patient revealed the need of 
azathiopurine as an immunosuppressant agent while steroid 
was tapering due to relapsing symptoms. Since the patient 
had been followed for only 3 months in our clinic, long 
term outcome is unavailable now. On the other hand, Goel 
et al reported that despite aggressive immunosuppression 
therapy, damage progressed in one-third of patients with 
childhood Takayasu’s arteritis [17].
In conclusion, children with Takayasu`s arteritis present 
with nonspecific symptoms. No laboratory test is diagnostic, 
but abnormalities in large vessels in radiology are specific 
for the disease. Mainstay of treatment is systemic steroid 
and outcome is worse in children than in adults.
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